The Efficacy and Optimal Dose of Sufentanil in Patient Controlled Analgesia After Moderate Surgery
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Effective postoperative pain control is essential for patients and inadequate postoperative
pain relief can cause mental and psychological sufferings. Despite the growing concern on
postoperative pain management, acute postoperative pain is still poorly managed. Though
numerous clinical practice guidelines for postoperative pain management have been published
throughout the last decades, inadequate pain relief remain a big health care issue.
Sufentanil has been used as satisfied pain control drug because of its strong potency of
analgesia for a long while. But its use in patient controlled intravenous analgesia (PCIA)
has not been clarified. And the dilemma of safety concern and insufficient dosage of
analgesic is a common problem. Thus the investigators design this prospective randomized
controlled double blinded trial to observe the efficacy and the optimal dose of sufentanil in
PCIA in patients underwent moderate surgery for the purpose of providing reference in
clinical practice.
Phase:
Phase 4
Details
Lead Sponsor:
Second Affiliated Hospital of Xi'an Jiaotong University